Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...

Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.

Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

SHOPPING: If you're ready to meet your weight goals, turn to Hims for personalized weight loss treatments that are ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Kyle Richards ' 25-year-old daughter Sophia Umansky has shared a "graphic" video of the extensive hair loss she has suffered after taking a weight loss drug for four months.

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health Organization.

An expert shared their opinion on the growing concern that Mounjaro, which is a popular GLP-1 weight loss medication, is ...